UNIFIED REGULATIONS FOR SCIENTIFIC COMMUNICATIONS FOR THE NEUROSCIENCE NURSING CONGRESS SEVILLE 2027

1. PURPOSE AND SCOPE OF APPLICATION

These regulations establish the criteria and requirements for the preparation, submission, evaluation, presentation, and publication of scientific communications (oral communications, posters, and clinical cases) at the 15th EANN Quadrennial Congress and 49th AEEN Annual Congress, Seville, Spain, May 5–7, 2027.

These regulations apply to all scientific communications submitted to the Congress, regardless of their modality and the authors’ country of origin.

2. TYPES OF ACCEPTED COMMUNICATIONS

The following modalities of scientific presentation will be accepted:

• Oral communication: A scientific work presented in a structured format before the audience, lasting approximately 12–20 minutes, followed by 4 minutes for questions and discussion. It must synthetically include the introduction, objectives, material and method, results, and discussion/conclusions, oriented towards the dissemination of research, clinical experiences, or projects relevant to nursing practice in neuroscience.
• Poster: A visual and structured presentation modality of a scientific work, in digital and/or printed format, designed to display clearly and summarily the objectives, method, results, and conclusions of the study, encouraging direct exchange between authors and attendees during the Congress.
• All accepted posters may be available in digital format on the platforms enabled by the organisation. Likewise, the Scientific Committee may select certain posters for public defence in a specific session for outstanding posters.
• The oral defence of the selected poster will have a maximum duration of 3 minutes, supported by a maximum of 3 slides, including, if deemed appropriate, the slide with the image of the poster. After the round of presentations, approximately 2 minutes will be reserved for questions.
• Selection for public defence will not necessarily alter the original poster modality, unless expressly communicated by the Scientific Committee.
• Clinical case: A work focused on the presentation and analysis of a case of clinical interest, including patient background, case description, data analysis, medical and nursing diagnoses, taxonomy used, and a reflection or discussion on its implications for clinical practice.
• Workshop or round table: A 60–90 minute session oriented towards small group discussion and the practical approach to a topic relevant to neuroscience nursing.

The Scientific Committee may determine the final form of presentation (oral, poster, workshop, or round table) based on the quality, originality, and score obtained in the evaluation.

3. GENERAL REQUIREMENTS FOR SCIENTIFIC COMMUNICATIONS

• Communications must be original, not previously published, nor presented at other congresses.
• The theme must be related to neuroscience nursing (neurological, neurosurgical, neurorehabilitation, intensive care, paediatrics, neuro-oncology, neuro-chronic care, operating theatre, emergencies, education, management, research, or other related fields).
• The maximum number of authors per communication will be 6 members.
• Registration for the Congress of at least one author will be essential, and registration of the author presenting the communication is compulsory.
• The language for presentation will be English in the main scientific sessions of the Congress, with simultaneous translation available. However, papers may be presented in Spanish in the specific room equipped with simultaneous translation for this purpose, ensuring comprehension by all attendees.
• Any conflict of interest related to the work must be explicitly communicated and stated in the presentation; in the event of funding or direct participation by the pharmaceutical industry, it must be specified and the work will not be eligible for a prize.

4. RULES FOR ABSTRACT SUBMISSION

4.1. General Characteristics of the Abstract

• The abstract must be submitted in Word or compatible format.
• Typography: Arial size 12 (for national congresses) or Times New Roman size 12 (when adjusting to international EANN regulations).
• Maximum length:
• Oral communications and posters: Maximum 300–500 words (depending on the specific call), including title and authors.
• Clinical cases: Maximum 300–500 words, following the structured template.
• The abstract will be submitted through the form enabled on the Congress website, under the communications section.
• The abstract must be accompanied by the declaration of authorship signed by the first author.

4.2. Structured Template for ORAL COMMUNICATIONS AND POSTERS

The abstract for an oral communication or poster must be completed using the structured template, including the following sections:

• Title.
• Authors and workplace.
• Keywords.
• Introduction – Objectives.
• Material and method.
• Results.
• Discussion / Conclusions.
• References: The publication style of the Vancouver rules will be used.

4.3. Structured Template for CLINICAL CASES

The clinical case abstract must include the following sections:

• Title.
• Authors and workplace.
• Patient background and introduction.
• Description of the clinical case: data analysis, medical diagnoses, nursing diagnoses, and taxonomy used.
• Reflection – Discussion on the clinical case, implications for nursing practice, and potential lines of improvement or research.
• References: The publication style of the Vancouver rules will be used.

4.4. Deadlines and Submission Procedure

• The deadline for abstract submission will be that established in the official call of the Congress.
• Receipt of submissions will be confirmed via email by the technical secretariat, who will assign a code to each communication for subsequent enquiries.
• Information regarding the email address and submission procedure will be available on the official Congress website.

5. DECLARATION OF AUTHORSHIP AND CONFLICTS OF INTEREST

• The first author must complete and sign the declaration of authorship, certifying that the proposed presentation is their original work (or joint work with other identified authors) and that all authors have participated significantly in the design, execution, analysis, and interpretation of the study or experience.
• The declaration of authorship will state that names, job titles, places of employment, qualifications, and the abstract (if accepted) may be published in the official Congress Programme and other dissemination media (newsletters, association website, etc.).
• Authors must explicitly declare any conflict of interest (financial, professional, institutional, academic) related to the work and make the corresponding mention in the oral presentation, poster, or workshop.
• In PowerPoint/Keynote presentations, it is recommended to include a declaration of the absence or presence of conflicts of interest on the first or second slide.

6. EVIDENCE-BASED SCIENTIFIC STRUCTURE CRITERIA

• Communications must adhere to methodological quality standards aligned with the recommendations of health sciences scientific journals.
• Use of updated bibliography (preferably from the last 5–10 years) and from journals indexed in recognised databases (PubMed/MEDLINE, CINAHL, Scopus, Web of Science, among others), following the Vancouver rules.
• Indicate whether the work has been carried out fully or partially with support from the pharmaceutical or technological industry, or any other commercial entity.

7. REGISTRATION AND PARTICIPATION IN THE CONGRESS

• Registration for the Congress of at least one author per communication will be essential.
• In all modalities, registration of the author presenting the communication is compulsory.
• Registration must be formalised before the deadline established in the call; otherwise, the communication cannot be presented, and the abstract will not be included in the book of communications.
• Authors are responsible for registration, travel, accommodation, and other expenses derived from their participation in the Congress.
• Works funded or carried out directly by the industry may be accepted, but will not be eligible for scientific prizes, unless by express and reasoned decision of the Scientific Committee.

8. EVALUATION OF ABSTRACTS AND FULL PAPERS

• The Scientific Committee will be responsible for the assessment and selection of works.
• All abstracts will be evaluated in a blind manner by members of the Scientific Committee, without identifying the authors or their institution of origin, following pre-established criteria in assessment tables.
• Assessment tables will include aspects such as:
  • a. Importance and relevance of the topic to neuroscience nursing.
  • b. Originality and innovation.
  • c. Methodological rigour and scientific quality.
  • d. Clarity in writing and structure of the work.
  • e. Future outlook and implication for nursing practice.
• In the case of EANN congresses, it will be respected that each country may have at least one abstract accepted, a circumstance that may influence the final decision for inclusion in the scientific programme.
• The Scientific Committee may modify the proposed presentation modality depending on the quality and structure of the work.

9. COMMUNICATION OF ACCEPTANCE AND PRESENTATION

• The technical secretariat will confirm receipt of abstracts and assign an identification code.
• The Scientific Committee will communicate the acceptance or rejection of papers before the established date, indicating the day and order of presentation, as well as the deadline for receiving digital posters.
• The final presentation modality (oral, poster, workshop, round table) will be communicated along with the acceptance.

10. ETHICAL ASPECTS AND CONFIDENTIALITY

• All works must comply with applicable ethical standards in health sciences research, including:
• a) Approval by a research ethics committee, where applicable.
• b) Obtaining informed consent in studies involving patients.
• c) Protection of personal data in accordance with current legislation.
• In clinical cases, patient anonymity will be guaranteed, and direct or indirect identifying data will be avoided.
• Communications must respect the principles of good clinical practice and professional ethics in nursing.

11. PRESENTATION OF COMMUNICATIONS DURING THE CONGRESS

• On the first day of the Congress, the responsible author must check that their presentation in PowerPoint or Keynote format has been received by the technical secretariat.
• The declaration of conflicts of interest must appear on the first or second slide.
• In the case of posters, authors of works that have not been selected for oral defence in the communications room must remain next to their poster during the time slot determined by the organisation, in order to answer enquiries from delegates and encourage scientific exchange.

FINAL PROVISIONS

• Any aspect not covered by these regulations will be resolved by the Congress Scientific Committee, which may issue supplementary instructions when deemed necessary.
• The regulations may be updated periodically to align with international best practices in nursing research and recommendations from health sciences scientific journals.
• Participation in the Congress implies acceptance of all provisions contained in these unified regulations for scientific communications.